一名既往对乙型肝炎病毒具有免疫力的患者发生肝细胞癌的病例。
A Hepatocellular Carcinoma Case in a Patient Who had Immunity to Hepatitis B Virus Earlier.
作者信息
Ates Ihsan, Kaplan Mustafa, Demirci Selim, Altiparmak Emin
机构信息
Department of Internal Medicine, Ankara Numune Education and Research Hospital, Sihhiye, Ankara, Turkey.
Department of Gastroenterology, Ankara Numune Education and Research Hospital, Sihhiye, Ankara, Turkey.
出版信息
Euroasian J Hepatogastroenterol. 2016 Jan-Jun;6(1):82-83. doi: 10.5005/jp-journals-10018-1173. Epub 2016 Jul 9.
Abstract
UNLABELLED
Hepatocellular carcinoma (HCC) is the most common malignant tumor of the liver. Hepatitis B virus infection is one of the most important etilogical factors of HCC. In this case report, a patient with HCC previously infected and having ongoing immunity against hepatitis B virus will be discussed.
HOW TO CITE THIS ARTICLE
Ates I, Kaplan M, Demirci S, Altiparmak E. A Hepatocellular Carcinoma Case in a Patient Who had Immunity to Hepatitis B Virus Earlier. Euroasian J Hepato-Gastroenterol 2016;6(1):82-83.
摘要
未标注
肝细胞癌（HCC）是肝脏最常见的恶性肿瘤。乙型肝炎病毒感染是HCC最重要的病因之一。在本病例报告中，将讨论一名先前感染过乙型肝炎病毒且对其具有持续免疫力的HCC患者。
如何引用本文
阿泰斯I，卡普兰M，德米尔西S，阿尔蒂帕尔马克E。一名既往对乙型肝炎病毒有免疫力的患者的肝细胞癌病例。《欧亚肝脏胃肠病学杂志》2016年；6（1）：82 - 83。
相似文献
1
A Hepatocellular Carcinoma Case in a Patient Who had Immunity to Hepatitis B Virus Earlier.一名既往对乙型肝炎病毒具有免疫力的患者发生肝细胞癌的病例。
Euroasian J Hepatogastroenterol. 2016 Jan-Jun;6(1):82-83. doi: 10.5005/jp-journals-10018-1173. Epub 2016 Jul 9.
2
Relationship between Hepatitis B Viral Deoxyribonucleic Acid Load and Hepatocellular Carcinoma.乙型肝炎病毒脱氧核糖核酸载量与肝细胞癌之间的关系
Euroasian J Hepatogastroenterol. 2017 Jan-Jun;7(1):111-112. doi: 10.5005/jp-journals-10018-1228. Epub 2017 May 5.
3
Management of Hepatocellular Carcinoma: Bangladesh Perspective.肝细胞癌的管理：孟加拉国视角
Euroasian J Hepatogastroenterol. 2018 Jan-Jun;8(1):52-53. doi: 10.5005/jp-journals-10018-1258. Epub 2018 May 1.
4
Epstein-Barr Virus and Cytomegalovirus induced Acute Hepatitis in Young Female Patient.爱泼斯坦-巴尔病毒和巨细胞病毒诱发年轻女性患者急性肝炎
Euroasian J Hepatogastroenterol. 2015 Jan-Jun;5(1):60-61. doi: 10.5005/jp-journals-10018-1134. Epub 2015 Jan 6.
5
Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy.乙型肝炎病毒感染期间宿主免疫的本质与免疫治疗设计
Euroasian J Hepatogastroenterol. 2018 Jan-Jun;8(1):42-46. doi: 10.5005/jp-journals-10018-1256. Epub 2018 May 1.
6
Viral Hepatitis and Liver Diseases in Mongolia.蒙古的病毒性肝炎与肝脏疾病
Euroasian J Hepatogastroenterol. 2017 Jan-Jun;7(1):68-72. doi: 10.5005/jp-journals-10018-1215. Epub 2017 May 5.
7
IP-10, p53, and Foxp3 Expression in Hepatocytes of Chronic Hepatitis B Patients with Cirrhosis and Hepatocellular Carcinoma.慢性乙型肝炎肝硬化和肝细胞癌患者肝细胞中IP-10、p53和Foxp3的表达
Euroasian J Hepatogastroenterol. 2016 Jul-Dec;6(2):149-153. doi: 10.5005/jp-journals-10018-1188. Epub 2016 Dec 1.
8
Epidemiology of Viral Hepatitis and Liver Diseases in Cambodia.柬埔寨病毒性肝炎与肝脏疾病的流行病学
Euroasian J Hepatogastroenterol. 2015 Jan-Jun;5(1):30-33. doi: 10.5005/jp-journals-10018-1125. Epub 2015 Jan 6.
9
Cost Assessment of Hepatitis B Virus-related Hepatitis in Bangladesh.孟加拉国乙型肝炎病毒相关肝炎的成本评估
Euroasian J Hepatogastroenterol. 2016 Jul-Dec;6(2):163-166. doi: 10.5005/jp-journals-10018-1190. Epub 2016 Dec 1.
10
Hepatitis in Malaysia: Past, Present, and Future.马来西亚的肝炎：过去、现在与未来
Euroasian J Hepatogastroenterol. 2016 Jan-Jun;6(1):52-55. doi: 10.5005/jp-journals-10018-1167. Epub 2016 Jul 9.
本文引用的文献
1
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.高水平的乙肝表面抗原会增加低 HBV 载量患者发生肝细胞癌的风险。
Gastroenterology. 2012 May;142(5):1140-1149.e3; quiz e13-4. doi: 10.1053/j.gastro.2012.02.007. Epub 2012 Feb 11.
2
Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.血清 HBV DNA 和丙氨酸氨基转移酶水平的变化可预测肝细胞癌的风险。
Gastroenterology. 2011 Oct;141(4):1240-8, 1248.e1-2. doi: 10.1053/j.gastro.2011.06.036. Epub 2011 Jun 22.
3
The etiology of hepatocellular carcinoma and consequences for treatment.肝细胞癌的病因学及其对治疗的影响。
Oncologist. 2010;15 Suppl 4:14-22. doi: 10.1634/theoncologist.2010-S4-14.
4
Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.携带不活动乙肝病毒的人仍然有患肝细胞癌和与肝脏相关死亡的风险。
Gastroenterology. 2010 May;138(5):1747-54. doi: 10.1053/j.gastro.2010.01.042. Epub 2010 Jan 28.
5
Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus.乙型肝炎表面抗原清除与乙型肝炎病毒慢性感染者肝细胞癌风险。
Hepatology. 2010 May;51(5):1531-7. doi: 10.1002/hep.23464.
6
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.血清乙型肝炎病毒DNA水平生物梯度上肝细胞癌的风险。
JAMA. 2006 Jan 4;295(1):65-73. doi: 10.1001/jama.295.1.65.
7
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study.丙型肝炎感染与肝细胞癌发病率上升：一项基于人群的研究。
Gastroenterology. 2004 Nov;127(5):1372-80. doi: 10.1053/j.gastro.2004.07.020.
8
Hepatitis B e antigen and the risk of hepatocellular carcinoma.乙肝e抗原与肝细胞癌风险
N Engl J Med. 2002 Jul 18;347(3):168-74. doi: 10.1056/NEJMoa013215.
9
A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.蒙特利尔无症状乙肝表面抗原阳性携带者的长期随访研究
Gastroenterology. 1994 Apr;106(4):1000-5. doi: 10.1016/0016-5085(94)90760-9.
10
Hepatitis B and C viruses in the development of hepatocellular carcinoma.乙型和丙型肝炎病毒在肝细胞癌发生发展中的作用
Crit Rev Oncol Hematol. 1994 Oct;17(2):71-91. doi: 10.1016/1040-8428(94)90020-5.
Zotero 插件